Proteome Sciences plc (LON:PRM – Get Free Report)’s share price traded down 15.1% during trading on Tuesday . The stock traded as low as GBX 2.35 ($0.03) and last traded at GBX 2.35 ($0.03). 343,488 shares were traded during trading, an increase of 117% from the average session volume of 158,279 shares. The stock had previously closed at GBX 2.77 ($0.04).
Proteome Sciences Stock Performance
The stock’s fifty day moving average is GBX 2.84 and its two-hundred day moving average is GBX 3.32. The firm has a market cap of £6.79 million, a price-to-earnings ratio of -277.50 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- Energy and Oil Stocks Explained
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Options Trading – Understanding Strike Price
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What Are Some of the Best Large-Cap Stocks to Buy?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
